elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33404952-323C5E30-FEC1-4382-A200-9797397E2C27
Q33404952-323C5E30-FEC1-4382-A200-9797397E2C27
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33404952-323C5E30-FEC1-4382-A200-9797397E2C27
A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study.
P2860
Q33404952-323C5E30-FEC1-4382-A200-9797397E2C27
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33404952-323C5E30-FEC1-4382-A200-9797397E2C27
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
805a2fde359769578e6d045ce2eaa1d3663c0587
P2860
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial